Update on continuous estrogen-progestin replacement therapy.
Estrogen replacement therapy is recommended for the prevention of osteoporosis and the attenuation of symptoms associated with menopause. Compliance may be a problem with sequential regimens of estrogen and progestin. To address this issue, continuous-dosing regimens of estrogen and progestin have been used. These regimens cause significantly less cyclic and intermenstrual bleeding and induce amenorrhea in most women, which should enhance compliance.
Rosenfeld
J A
JA
East Tennessee State University, Bristol.
D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D015914:Estrogen Replacement Therapy / Q000379:methods*; D004967:Estrogens / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control; D010349:Patient Compliance; D017410:Practice Guidelines as Topic; D011372:Progestins / Q000008:administration & dosage*
D004967:Estrogens; D011372:Progestins